Perioperative monitoring of haemostasis is essential to detect causes of haemorrhage and guide haemostatic therapy. 1 Assessing the viscoelastic properties of blood samples using rotation thromboelastometry provides information on platelet function, clot formation, and fibrinolysis. 2 Rotation thromboelastometry is increasingly used for haemostatic management in trauma, cardiac, or hepatic surgery. 3 -5 Thromboelastometry as point-of-care (POC) testing enables the analysis of the clotting process at the bedside, thus providing rapid results to guide therapy. 2 However, POC testing requires medical staff who are also managing critically ill patients as non-laboratory personnel may not be sufficiently trained to run the devices. 2 To resolve these problems, thromboelastometry can be performed in the central laboratory and real-time thromboelastometric reaction curves can be transmitted online to the patient's location. 2 A frequently chosen technique for intra-hospital transport of blood samples is the pneumatic tube system (PTS). This technique enables the laboratory to provide analytical services with turnaround times comparable with those of a POC testing facility. 6 However, samples are subjected to accelerations and decelerations, changes in air pressure, and vibrations during transport. No significant preanalytical effects of PTS transport have been noted for most routine haematology and coagulation parameters. 7 8 A small study thromboelastographic parameters using a TEG 5000 w demonstrating decreased reaction times. 8 Studies investigating the effects of PTS transport on rotation thromboelastometry are lacking. We evaluated a clinical setting in which blood samples would not be analysed promptly at the bedside but with a short delay in a core laboratory after PTS transport. This study compares ROTEM w thromboelastometry parameters of blood samples analysed immediately with those analysed after PTS transport.
Methods
The study was approved by the Institutional Review Board of the medical faculty of the Technical University Munich. We prospectively studied thromboelastometric parameters of 92 patients with normal haemostasis treated in our intensive care unit (ICU). An overview of patient characteristics and standard coagulation parameters are presented in Table 1 . Exclusion criteria included treatment with anti-platelet drugs, heparin or coumarin, known coagulation disorders, known renal diseases or serum creatinine .120 mmol litre 21 , and known liver diseases or plasma concentration of alanine aminotransferase .50 U litre 21 .
Activated rotation thromboelastometry was performed using a computerized ROTEM w 5 device (Rotation Thromboelastometry, Pentapharm w GmbH, Munich, Germany) to investigate clot firmness, coagulation time (CT), clot formation time (CFT), a-angle, and clot-lysis. The thromboelastometry technique has been described in detail elsewhere. 9 10 Three assays were studied: INTEM, for which coagulation is activated with ellagic acid; EXTEM, for which tissue factor (TF) is used for activation; FIBTEM, for which TF activates coagulation, but the contribution of platelets to clot formation is inhibited by cytochalasin D.
In this study, a single ROTEM w 5 device with four measurement channels was used, and each channel can independently perform a single test. One specific assay (EXTEM, INTEM, or FIBTEM) was investigated in each of the 92 patients (INTEM, n¼35; EXTEM, n¼27; FIBTEM, n¼30). Two arterial blood samples were collected from each patient in citrated plastic tubes (S-Monovette w , 0.106 mol litre 21 sodium citrate, Sarstedt GmbH, Germany) via an arterial line.
One sample, referred to as POC sample, was immediately analysed in the ICU with the specific assay to be investigated (EXTEM, INTEM, or FIBTEM).
The second sample, referred to as PTS sample, was sent in a transport container to a nearby facility via PTS (Swisslog w , Westerstede, Germany). The transport container travelled at a velocity of 6-8 m s 21 for 50 s and was discharged perpendicularly without a preceding retardation. To eliminate interdevice imprecision, the PTS sample was hand-carried back to the ICU and analysed with the same device and the same assay as the POC sample.
To increase accuracy, analyses of the POC and PTS samples were performed in duplicate simultaneously hereby using all four measurement channels of the thromboelastograph. All four measurements were run for 90 min. The analysis of the PTS sample started 10 min after analysis start of the POC sample.
The use of a single device is advocated if small differences are of importance since significant differences for ROTEM w parameters were found when analysing blood on different devices. 11 To exclude effects due to differences in the duration of citrate anticoagulation between POC and PTS samples, we used the Spearman rank correlation coefficient (r). For each variable, an examination was made of the correlation between the time interval between the PTS and POC measurements vs the difference between the measurements. As a non-parametric measure of bivariate relationship, Spearman's r is robust against impact of high leverage points and is particularly appropriate when assessing nonnormal distributed data. According to the definition of Fowler and colleagues, 12 an absolute value of correlation coefficient ,0.39 is considered to indicate a weak correlation. The mean systematic differences between PTS samples and POC samples were calculated with 95% confidence intervals (CIs). A CI excluding the zero value indicates a statistically significant bias with P,0.05. Standard deviations (SDs) of systematic differences were also calculated, permitting assessment of the distribution of individual deviations between PTS and POC samples. The concordance correlation coefficient (CCC) proposed by Lin 13 was used to evaluate the reproducibility and comparability of repeated quantitative measurements considering both accuracy and precision. Accordingly, the bias correction factor (BCF) was reported, which measures how far the best-fit line in a PTS vs POC coordinate plane deviates from the optimal line at 458 with perfect agreement. No deviation from the 458 line occurs when BCF¼1, and possible BCF values range from .0 to 1. By definition, Lin's CCC is determined by the product of Pearson's correlation coefficient (R) and the BCF (CCC¼R×BCF). Thus, both the systematic deviation and the correlation of the two measurements are combined in one index with values from 21 to +1. The coefficient of variation (CV) was determined using recommended root mean square averages to quantify the variability of repeated measurements within PTS and POC samples.
14 Statistical analyses were performed using SPSS 16.0 software (SPSS Inc., Chicago, IL, USA) and the statistical software package 'R' version 2.7.1 with the function epi.ccc. 15 16 Statistical comparisons were performed at a two-tailed 0.05 level of significance.
Results
The thromboelastometry data are presented in Table 2 . The results of the statistical analyses are presented in Table 3 . Although statistically significant differences between PTS and POC samples were seen in various parameters, the magnitude of these changes was small. INTEM CFT, a CV of about 4% was determined in POC and PTS samples. For EXTEM CFT, slightly lower CVs of 3.2% and 3.7% were determined in POC and PTS samples, respectively. In FIBTEM clot firmness values, no significant differences were observed between PTS and POC samples. CCC and BCF values were 0.99 for these parameters. Higher CVs were observed for PTS samples.
The median time differences in analysis start between POC and PTS samples were similar throughout the measurements. In the INTEM and EXTEM assays, analysis of the PTS sample started 11 min after start of analysis of the POC sample. In the FIBTEM assay, analysis of the PTS sample started 10 min later. No relevant dependencies between measurement biases and differences in the duration of citrate storage of POC and PTS samples were found (Spearman's r coefficients ,|0.25|, P.0.15).
Discussion
The aim of our study was to evaluate a common clinical setting in which blood samples are not analysed promptly at the bedside but after a brief delay in a remote laboratory after PTS transport. The ease of access and fast transport of blood samples make PTS ideal for clinician use. Its use is based on the premise that the quality of the results obtained after transport is clinically acceptable. Our results demonstrate in PTS samples a decrease in INTEM CT, an increase in EXTEM CT, and a reduction in INTEM and EXTEM clot firmness values.
Coagulation time
The reduction in INTEM CT in the PTS samples is consistent with a previous report on preanalytical effects of PTS transport on thromboelastography. 8 Wallin and colleagues 8 used a TEG 5000 w instrument and demonstrated a decreased time to clot formation in citrate-anticoagulated samples after PTS transport. Possible mechanisms for the decrease in INTEM CT are inherent activation of the sample due to agitation or enhancement of procoagulant effects at surfaces of the sample vessel during PTS transport.
The EXTEM CT was increased in PTS samples. Possibly, the lower EXTEM CT in the POC samples was due to a not completely inhibited coagulation cascade at the time of analysis, since POC samples were analysed immediately sampling. Theusinger and colleagues 11 found slightly higher, but not statistically significant, EXTEM CT and INTEM CT values after 30 min of storage. In contrast to the INTEM CT measurements, PTS transport seems to have no procoagulant effects on EXTEM CT. This might be attributed to the use of TF as a powerful activator of coagulation in the EXTEM assay which may override effects of PTS transport.
Clot firmness
Clot firmness values were decreased after PTS transport in the INTEM and EXTEM assays but not in the FIBTEM assay.
Since the contribution of platelets to haemostasis is inhibited in FIBTEM, the reduced clot firmness in INTEM and EXTEM can be attributed to platelet dysfunction. Previous studies evaluated the effects of PTS transport on in vitro platelet function using a platelet function analyser (PFA-100 TM ) and whole blood platelet aggregation: in healthy volunteers, no differences in PFA closure times between PTS and non-PTS samples were found. In subjects treated with acetylsalicylic acid (ASA), Wallin and colleagues 8 did not demonstrate an effect of PTS transport, while Dyszkiewicz-Korpanty and colleagues 17 detected increased closure times in PTS samples using cartridges with adenosine diphosphate. DyszkiewiczKorpanty and colleagues 17 also assessed platelet function by whole blood platelet aggregation and found a decreased aggregation in PTS samples of subjects treated with ASA. In a recent study using Multiplate TM impedance aggregometry, sample transport by PTS affected in vitro platelet function. 18 Taken together, the majority of these studies suggest that platelets are affected by PTS transport which corresponds to our findings of decreased clot firmness values in PTS samples. To our knowledge, only one previous study with a rather small sample size analysed the effects of PTS transport on thromboelastographic values using a TEG 5000 w instrument. 8 Wallin and colleagues analysed nine samples from volunteers without prior ASA intake and five samples after ASA intake and showed no significant effect of PTS transport on clot firmness. In contrast, we observed reduced clot firmness values after PTS transport in the INTEM and EXTEM measurements. PTS samples underwent 10 additional minutes of citrate anticoagulation before analysis in comparison with the POC samples. In previous studies, decreased amplitudes and reaction times during citrate storage were observed, but these samples were subjected to repeated sampling which appears to activate coagulation in the sample. 19 20 In our study, samples were not subjected to repeated sampling. Vig and colleagues 21 observed no effects on reaction time or amplitudes in citrate-anticoagulated samples stored for ,30 min when using celite to activate coagulation. In a recent study by Theusinger and colleagues, 11 no differences in EXTEM, INTEM, and FIBTEM assays over 2 h of storage were detected. In our study, the same assays were used and we did not show an influence of the different durations of citrate anticoagulation between POC and PTS samples. Theusinger and colleagues 11 further emphasize the practical relevance of their results, since the exact delay from blood drawing to testing would be difficult to standardize. The alterations of thromboelastometric parameters in blood samples analysed after PTS transport compared with POC samples are statistically significant but in the view of the authors without clinical consequence. A decrease in INTEM or EXTEM clot firmness values of 1-2 mm at various time points (e.g. EXTEM A10, reference range 43 -65 mm; e.g. INTEM/EXTEM MCF, reference range 50-72 mm) in the PTS transported samples should not alter clinical decision-making (see Table 2 for reference values). Similarly, the increase in EXTEM CT of 4 s in the PTS samples should not influence haemostatic therapy, given the reference range of 38 -79 s. Correspondingly, the reduction in INTEM CT values by a mean of 13 s is negligible in the view of a normal range between 100 and 240 s.
Conclusion
This study demonstrates that ROTEM w thromboelastometry parameters of blood samples analysed after PTS transport are significantly altered compared with samples analysed in a POC setting. In patients with normal haemostasis, the decrease in INTEM CT, the increase in EXTEM CT, and the reduction in INTEM and EXTEM clot firmness values are without clinical consequence. Rotation thromboelastometry analysis in a core laboratory after PTS transport is an acceptable alternative to the analysis at the bedside. However, further studies should focus on patients with impaired haemostasis.
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